Semaglutide
8 NDCs across 1 manufacturer|0 Generic,8 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 5, 2017. In 2024, Medicare Part D spent $15.2 billion on Semaglutide across 11.9 million claims for 2.3 million beneficiaries.
Semaglutide is available as 8 NDCs from 1 manufacturer (0 generic, 8 brand), with NADAC prices from $331.90 to $653.37 per ML — a 97% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
0G / 8B
Manufacturers
1
competing in market
Price Spread
$331.90 – $653.37
per ML
7d Activity
avg -0.0% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SEMAGLUTIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
WEGOVY 0.25 MG/0.5 ML PEN | $653.3673 per ML | 0.00% |
WEGOVY 0.5 MG/0.5 ML PEN | $653.2446 per ML | -0.03% |
WEGOVY 1 MG/0.5 ML PEN | $653.0409 per ML | -0.06% |
WEGOVY 1.7 MG/0.75 ML PEN | $435.4008 per ML | -0.05% |
WEGOVY 2.4 MG/0.75 ML PEN | $435.3578 per ML | -0.05% |
OZEMPIC 0.25-0.5 MG/DOSE (2 MG/3 ML) PEN | $331.9701 per ML | 0.00% |
OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN | $331.9436 per ML | 0.00% |
OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN | $331.8987 per ML | 0.00% |
Frequently Asked Questions
How much does Medicare spend on Semaglutide?
In 2024, Medicare Part D spent $15.2 billion on Semaglutide across 11.9 million claims for 2.3 million beneficiaries.
How many Semaglutide products are on the market?
The Semaglutide drug market contains 8 NDCs from 1 manufacturer — 0 generic and 8 brand products.
What is the price range for Semaglutide?
NADAC reference prices for Semaglutide range from $331.8987 to $653.3673 per ML — a 97% difference between cheapest and most expensive.
Which manufacturers make Semaglutide?
1 manufacturer lists Semaglutide in NADAC. Ranked by number of NDCs, the largest are Novo Nordisk (8).
How has the price of Semaglutide changed recently?
Over the past 7 days, 0 Semaglutide NDCs rose and 4 fell, with a market-wide average change of -0.0%.